(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Potbelly Corporation, Patriot National Bancorp, and RiceBran Technologies.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Potbelly Corporation (PBPB) | 8.17 | 10.26% | 2023-10-17 23:47:05 |
| 2 | Patriot National Bancorp (PNBK) | 6.98 | 8.89% | 2023-10-18 04:41:06 |
| 3 | RiceBran Technologies (RIBT) | 0.41 | 8.84% | 2023-10-18 13:43:05 |
| 4 | Perma-Fix Environmental Services (PESI) | 10.29 | 7.3% | 2023-10-18 01:43:05 |
| 5 | Profire Energy (PFIE) | 2.34 | 5.88% | 2023-10-18 03:07:05 |
| 6 | Rocky Brands (RCKY) | 15.38 | 5.63% | 2023-10-18 11:15:05 |
| 7 | Oxbridge Re Holdings Limited (OXBR) | 1.58 | 5.33% | 2023-10-17 23:06:05 |
| 8 | Nasdaq Inc (NDAQ) | 52.41 | 4.97% | 2023-10-18 12:13:49 |
| 9 | DexCom (DXCM) | 84.18 | 4.58% | 2023-10-18 12:11:48 |
| 10 | PetMed Express (PETS) | 10.52 | 4.52% | 2023-10-18 01:44:05 |
The three biggest losers today are Bionano Genomics, Ultragenyx Pharmaceutical, and Prothena Corporation plc.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Bionano Genomics (BNGO) | 1.88 | -10.9% | 2023-10-18 12:15:46 |
| 2 | Ultragenyx Pharmaceutical (RARE) | 32.84 | -10.83% | 2023-10-18 11:10:05 |
| 3 | Prothena Corporation plc (PRTA) | 47.13 | -9.92% | 2023-10-18 07:06:06 |
| 4 | Albemarle (ALB) | 154.01 | -9.13% | 2023-10-18 12:18:06 |
| 5 | FuelCell Energy (FCEL) | 1.27 | -8.96% | 2023-10-18 12:12:08 |
| 6 | Ebix (EBIX) | 6.04 | -8.76% | 2023-10-18 12:11:54 |
| 7 | Aspen Group (ASPU) | 0.16 | -8.57% | 2023-10-18 12:15:39 |
| 8 | Plug Power (PLUG) | 7.09 | -8.17% | 2023-10-18 12:14:09 |
| 9 | Cliffs Natural Resources (CLF) | 14.32 | -8.11% | 2023-10-18 12:53:37 |
| 10 | Gevo (GEVO) | 1.10 | -7.98% | 2023-10-18 12:12:33 |
Winners today
1. Potbelly Corporation (PBPB) – 10.26%
Potbelly Corporation, through its subsidiaries, owns, operates, and franchises Potbelly sandwich shops. As of December 26, 2021, it had 443 shops in 33 states and the District of Columbia, which included 397 shops and 46 franchisees operated shops. The company was formerly known as Potbelly Sandwich Works, Inc. and changed its name to Potbelly Corporation in 2002. Potbelly Corporation was founded in 1977 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with Potbelly Corporation jumping 10.26% to $8.17 on Wednesday while NASDAQ fell 1.62% to $13,314.30.
Earnings Per Share
As for profitability, Potbelly Corporation has a trailing twelve months EPS of $0.43.
PE Ratio
Potbelly Corporation has a trailing twelve months price to earnings ratio of 19. Meaning, the purchaser of the share is investing $19 for every dollar of annual earnings.
More news about Potbelly Corporation.
2. Patriot National Bancorp (PNBK) – 8.89%
Patriot National Bancorp, Inc. operates as the holding company for Patriot Bank, N.A. that provides community banking services to individuals, small and medium-sized businesses, and professionals. The company accepts consumer and commercial deposit accounts, such as checking, interest-bearing negotiable order of withdrawal, money market, savings, prepaid deposit, on-line national money market, individual retirement accounts, and health savings accounts, as well as certificate of deposit account registry service. Its loan portfolio comprises commercial real estate, commercial business, small business administration, construction, purchased residential real estate, and various consumer loans. The company also offers automated clearing house transfers, lockbox, Internet banking, bill payment, remote deposit capture, debit card, money order, traveler's check, and automatic teller machine services. It operated through a network of eight branch offices located in Fairfield and New Haven Counties, Connecticut; and one branch offices located in Westchester County, New York. The company was founded in 1994 and is headquartered in Stamford, Connecticut.
NASDAQ ended the session with Patriot National Bancorp rising 8.89% to $6.98 on Wednesday, following the last session’s upward trend. NASDAQ slid 1.62% to $13,314.30, following the last session’s downward trend on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, Patriot National Bancorp has a trailing twelve months EPS of $0.86.
PE Ratio
Patriot National Bancorp has a trailing twelve months price to earnings ratio of 8.12. Meaning, the purchaser of the share is investing $8.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.23%.
More news about Patriot National Bancorp.
3. RiceBran Technologies (RIBT) – 8.84%
RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. Its SRB and derivative products are nutritional and beneficial food products that contain a combination of oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants that enhance the nutritional value of consumer products. The company's SRB products are also marketed as feed ingredients in the animal nutrition markets. It serves food and animal nutrition manufacturers, wholesalers, and retailers in the United States and internationally. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.
NASDAQ ended the session with RiceBran Technologies rising 8.84% to $0.41 on Wednesday while NASDAQ dropped 1.62% to $13,314.30.
Earnings Per Share
As for profitability, RiceBran Technologies has a trailing twelve months EPS of $-1.24.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -93.64%.
Volume
Today’s last reported volume for RiceBran Technologies is 38589 which is 29.29% below its average volume of 54576.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.7%, now sitting on 41.16M for the twelve trailing months.
Moving Average
RiceBran Technologies’s value is way under its 50-day moving average of $0.55 and way under its 200-day moving average of $0.88.
Earnings Before Interest, Taxes, Depreciation, and Amortization
RiceBran Technologies’s EBITDA is -8.13.
More news about RiceBran Technologies.
4. Perma-Fix Environmental Services (PESI) – 7.3%
Perma-Fix Environmental Services, Inc., through its subsidiaries, operates as an environmental and technology know-how company in the United States. It operates in three segments: Treatment, Services, and Medical. The Treatment segment offers nuclear, low-level radioactive, mixed waste, hazardous and non-hazardous waste treatment, and processing and disposal services through treatment and storage facilities. This segment is also involved in the research and development activities to identify, develop, and implement waste processing techniques for problematic waste streams. The Services segment provides technical services, including professional radiological measurement and site survey of government and commercial installations; integrated occupational safety and health services; and consulting, engineering, project and waste management, environmental, decontamination and decommissioning (D&D) field, technical, on-site waste management services, and management personnel and services. This segment also offers nuclear services, including technology-based services comprising engineering, D&D, specialty, construction, logistics, transportation, processing, and disposal; offers remediation of nuclear licensed and federal facilities, as well as cleanup of nuclear legacy sites; and owns an equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources health physics, industrial hygiene, and customized nuclear, environmental, and occupational safety and health instrumentation. The Medical segment is involved in the research and development of medical isotope production technology. The company provides its services to research institutions, commercial companies, public utilities, and governmental agencies through direct sales to customers or through intermediaries. Perma-Fix Environmental Services, Inc. was incorporated in 1990 and is based in Atlanta, Georgia.
NASDAQ ended the session with Perma-Fix Environmental Services rising 7.3% to $10.29 on Wednesday while NASDAQ dropped 1.62% to $13,314.30.
Earnings Per Share
As for profitability, Perma-Fix Environmental Services has a trailing twelve months EPS of $-0.04.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.32%.
Moving Average
Perma-Fix Environmental Services’s worth is under its 50-day moving average of $11.41 and way above its 200-day moving average of $9.34.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Perma-Fix Environmental Services’s EBITDA is 87.33.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.7%, now sitting on 80.37M for the twelve trailing months.
Yearly Top and Bottom Value
Perma-Fix Environmental Services’s stock is valued at $10.29 at 17:32 EST, way below its 52-week high of $13.87 and way above its 52-week low of $3.20.
More news about Perma-Fix Environmental Services.
5. Profire Energy (PFIE) – 5.88%
Profire Energy, Inc., a technology company, provides burner, and combustion management systems and solutions for natural and forced draft applications in the United States and Canada. It primarily focuses on the upstream, midstream, and downstream transmission segments of the oil and gas industry. It also sells and installs its systems in Europe, South America, Africa, the Middle East, and Asia. The company was founded in 2002 and is based in Lindon, Utah.
NASDAQ ended the session with Profire Energy jumping 5.88% to $2.34 on Wednesday, after three sequential sessions in a row of gains. NASDAQ slid 1.62% to $13,314.30, following the last session’s downward trend on what was an all-around down trend exchanging session today.
Earnings Per Share
As for profitability, Profire Energy has a trailing twelve months EPS of $0.17.
PE Ratio
Profire Energy has a trailing twelve months price to earnings ratio of 13.76. Meaning, the purchaser of the share is investing $13.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.51%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 100% and 25%, respectively.
More news about Profire Energy.
6. Rocky Brands (RCKY) – 5.63%
Rocky Brands, Inc. designs, manufactures, and markets footwear and apparel under the Rocky, Georgia Boot, Durango, Lehigh, Muck, XTRATUF, Servus, NEOS, Ranger, and licensed Michelin brand names in the United States, Canada, and internationally. It operates through Wholesale, Retail, and Contract Manufacturing segments. The Wholesale segment offers products in approximately 10,000 retail locations through a range of distribution channels comprising sporting goods stores, outdoor retailers, independent shoe retailers, hardware stores, catalogs, mass merchants, uniform stores, farm store chains, specialty safety stores, and specialty and online retailers. The Retail segment sells its products directly to consumers through its e-commerce websites, including rockyboots.com, georgiaboot.com, durangoboot.com, lehighoutfitters.com, lehighsafetyshoes.com, slipgrips.com,muckbootcompany.com,xtratuf.com, and Rocky outlet store in Nelsonville, Ohio, and retail stores. The Contract Manufacturing segment include private label sales and any sales to customers which are contracted to manufacture a specific footwear product for a customer and include sales to the U.S. Military. It serves industrial and construction workers, as well as workers in the hospitality industry, such as restaurants or hotels; farmers and ranchers; consumers enamored with western influenced fashion; commercial military personnel; hunting, fishing, camping, and hiking enthusiasts; law enforcement, security personnel, and postal employees; and for the U.S. military personnel. Rocky Brands, Inc. was founded in 1932 and is headquartered in Nelsonville, Ohio.
NASDAQ ended the session with Rocky Brands rising 5.63% to $15.38 on Wednesday while NASDAQ slid 1.62% to $13,314.30.
Earnings Per Share
As for profitability, Rocky Brands has a trailing twelve months EPS of $1.24.
PE Ratio
Rocky Brands has a trailing twelve months price to earnings ratio of 12.4. Meaning, the purchaser of the share is investing $12.4 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.38%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Rocky Brands’s EBITDA is 171.11.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 34.9% and a negative 5.6%, respectively.
Sales Growth
Rocky Brands’s sales growth is negative 18.6% for the present quarter and negative 1.4% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Aug 30, 2023, the estimated forward annual dividend rate is 0.62 and the estimated forward annual dividend yield is 4.45%.
More news about Rocky Brands.
7. Oxbridge Re Holdings Limited (OXBR) – 5.33%
Oxbridge Re Holdings Limited, together with its subsidiaries, provides specialty property and casualty reinsurance solutions. It underwrites reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. The company distributes its products and solutions through reinsurance brokers. Oxbridge Re Holdings Limited was incorporated in 2013 and is headquartered in George Town, the Cayman Islands.
NASDAQ ended the session with Oxbridge Re Holdings Limited rising 5.33% to $1.58 on Wednesday while NASDAQ fell 1.62% to $13,314.30.
Earnings Per Share
As for profitability, Oxbridge Re Holdings Limited has a trailing twelve months EPS of $-0.25.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.01%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 37.4%, now sitting on 1.58M for the twelve trailing months.
More news about Oxbridge Re Holdings Limited.
8. Nasdaq Inc (NDAQ) – 4.97%
Nasdaq, Inc. operates as a technology company that serves capital markets and other industries worldwide. It operates in three segments: Market Platforms, Capital Access Platforms, and Anti-Financial Crime. The Market Platforms segment trading services, including equity derivative trading and clearing, cash equity trading, fixed income and commodities trading and clearing, and trade management service businesses. This segment operates various exchanges and other marketplace facilities across various asset classes, which include derivatives, commodities, cash equity, debt, structured products, and exchange traded products; and provides broker, clearing, settlement, and central depository services. This segment also handles assets, such as cash equities, equity derivatives, currencies, interest-bearing securities, commodities, energy products, and digital currencies. The Capital Access Platforms segment sells and distributes historical and real-time market data; develops and licenses Nasdaq-branded indexes and financial products; operates listing platforms; investment insights and workflow solutions; and offers investor relations intelligence, ESG solutions, and governance solutions. The Anti-Financial Crime segment includes anti financial crime management solutions, which offers Nasdaq Trade Surveillance, a SaaS solution for brokers and other market participants to assist them in complying with market rules, regulations, and internal market surveillance policies; Nasdaq Market Surveillance, a market surveillance solution for markets and regulators; and Verafin, a SaaS technology provider of anti-financial crime management solutions. The company was formerly known as The NASDAQ OMX Group, Inc. and changed its name to Nasdaq, Inc. in September 2015. Nasdaq, Inc. was founded in 1971 and is headquartered in New York, New York.
NASDAQ ended the session with Nasdaq Inc jumping 4.97% to $52.41 on Wednesday, following the last session’s downward trend. NASDAQ dropped 1.62% to $13,314.30, following the last session’s downward trend on what was an all-around bearish trend trading session today.
Earnings Per Share
As for profitability, Nasdaq Inc has a trailing twelve months EPS of $2.23.
PE Ratio
Nasdaq Inc has a trailing twelve months price to earnings ratio of 23.5. Meaning, the purchaser of the share is investing $23.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.2%.
Volume
Today’s last reported volume for Nasdaq Inc is 4393580 which is 69.05% above its average volume of 2598900.
Revenue Growth
Year-on-year quarterly revenue growth declined by 7.7%, now sitting on 6.1B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Sep 13, 2023, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 1.78%.
More news about Nasdaq Inc.
9. DexCom (DXCM) – 4.58%
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
NASDAQ ended the session with DexCom jumping 4.58% to $84.18 on Wednesday while NASDAQ slid 1.62% to $13,314.30.
Earnings Per Share
As for profitability, DexCom has a trailing twelve months EPS of $0.86.
PE Ratio
DexCom has a trailing twelve months price to earnings ratio of 97.88. Meaning, the purchaser of the share is investing $97.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.41%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 0.41%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
DexCom’s EBITDA is 294.75.
Sales Growth
DexCom’s sales growth is 25% for the present quarter and 22% for the next.
Previous days news about DexCom
- Why the market dipped but dexcom (dxcm) gained today. According to Zacks on Tuesday, 17 October, "In the latest trading session, DexCom (DXCM Quick QuoteDXCM – Free Report) closed at $80.49, marking a +1.95% move from the previous day. ", "Valuation is also important, so investors should note that DexCom has a Forward P/E ratio of 64.14 right now. "
More news about DexCom.
10. PetMed Express (PETS) – 4.52%
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
NASDAQ ended the session with PetMed Express rising 4.52% to $10.52 on Wednesday while NASDAQ dropped 1.62% to $13,314.30.
Earnings Per Share
As for profitability, PetMed Express has a trailing twelve months EPS of $-0.18.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.65%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 10, 2023, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 11.94%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
PetMed Express’s EBITDA is -417.46.
Yearly Top and Bottom Value
PetMed Express’s stock is valued at $10.52 at 17:32 EST, way below its 52-week high of $22.64 and way higher than its 52-week low of $9.30.
More news about PetMed Express.
Losers Today
1. Bionano Genomics (BNGO) – -10.9%
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.
NASDAQ ended the session with Bionano Genomics dropping 10.9% to $1.88 on Wednesday while NASDAQ slid 1.62% to $13,314.30.
Earnings Per Share
As for profitability, Bionano Genomics has a trailing twelve months EPS of $-6.85.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.67%.
More news about Bionano Genomics.
2. Ultragenyx Pharmaceutical (RARE) – -10.83%
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc., Solid Biosciences Inc.; and Daiichi Sankyo Co., Ltd. Ultragenyx Pharmaceutical Inc. was incorporated in 2010 and is headquartered in Novato, California.
NASDAQ ended the session with Ultragenyx Pharmaceutical falling 10.83% to $32.84 on Wednesday while NASDAQ dropped 1.62% to $13,314.30.
Earnings Per Share
As for profitability, Ultragenyx Pharmaceutical has a trailing twelve months EPS of $-11.63.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -178.6%.
Volume
Today’s last reported volume for Ultragenyx Pharmaceutical is 1211650 which is 72.6% above its average volume of 701967.
More news about Ultragenyx Pharmaceutical.
3. Prothena Corporation plc (PRTA) – -9.92%
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease; PRX004 that completed Phase I clinical trial for the treatment of Transthyretin amyloidosis; and PRX005, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its discovery and preclinical programs include PRX012 for the treatment of Alzheimer's disease; and dual Aß-Tau vaccine for the treatment and prevention of Alzheimer's disease. Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. The company was founded in 2012 and is based in Dublin, Ireland.
NASDAQ ended the session with Prothena Corporation plc falling 9.92% to $47.13 on Wednesday, following the last session’s downward trend. NASDAQ fell 1.62% to $13,314.30, following the last session’s downward trend on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, Prothena Corporation plc has a trailing twelve months EPS of $-2.92.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.49%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 206.3%, now sitting on 57.63M for the twelve trailing months.
Yearly Top and Bottom Value
Prothena Corporation plc’s stock is valued at $47.13 at 17:32 EST, way below its 52-week high of $79.65 and higher than its 52-week low of $43.60.
More news about Prothena Corporation plc.
4. Albemarle (ALB) – -9.13%
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based products used in fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
NYSE ended the session with Albemarle sliding 9.13% to $154.01 on Wednesday while NYSE slid 1.39% to $15,324.96.
Earnings Per Share
As for profitability, Albemarle has a trailing twelve months EPS of $33.25.
PE Ratio
Albemarle has a trailing twelve months price to earnings ratio of 4.63. Meaning, the purchaser of the share is investing $4.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 49.38%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Albemarle’s EBITDA is 96.94.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 45.6% and a negative 44.2%, respectively.
Moving Average
Albemarle’s worth is way under its 50-day moving average of $180.43 and way below its 200-day moving average of $213.82.
Previous days news about Albemarle
- Albemarle (alb) withdraws offer to acquire liontown resources. According to Zacks on Monday, 16 October, "Shares of Albemarle have lost 34.1% in the past year against a 4.2% rise of theindustry.", "In its second-quarter call, Albemarle raised its 2023 outlook, anticipating a boost from rising lithium market prices and a continued global shift towards electric vehicles. "
More news about Albemarle.
5. FuelCell Energy (FCEL) – -8.96%
FuelCell Energy, Inc., together with its subsidiaries, manufactures and sells stationary fuel cell energy platforms that decarbonize power and produce hydrogen. It offers SureSource 1500, a 1.4-megawatt (MW) platform; SureSource 3000, a 2.8 MW platform; SureSource 4000, a 3.7 MW platform; SureSource 250, a 250- kilowatt (kW) platform; SureSource 400, a 400-kW platform; and SureSource Hydrogen, a 2.3 MW platform that is designed to produce up to 1,200 kilograms of hydrogen per day for multi-megawatt utility, microgrid, and distributed hydrogen applications, as well as on-site heat and chilling applications. The company also provides SureSource platform in various configurations and applications, including on-site power, utility grid support, and microgrid, as well as distributed hydrogen; solutions for long duration hydrogen-based energy storage and electrolysis technology; and carbon capture, separation, and utilization systems. Its SureSource power plants generate electricity, heat, hydrogen, and water. In addition, the company provides turn-key solutions, including development, engineering, procurement, construction, interconnection, and operation services. It serves various markets, including utilities and independent power producers, industrial and process applications, education and health care, data centers and communication, wastewater treatment, government, microgrids, hydrogen transportation, food and beverage, and commercial and hospitality. The company primarily operates in the United States, South Korea, England, Germany, and Switzerland. FuelCell Energy, Inc. was founded in 1969 and is headquartered in Danbury, Connecticut.
NASDAQ ended the session with FuelCell Energy sliding 8.96% to $1.27 on Wednesday, following the last session’s upward trend. NASDAQ slid 1.62% to $13,314.30, following the last session’s downward trend on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, FuelCell Energy has a trailing twelve months EPS of $-0.3.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.79%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FuelCell Energy’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth declined by 40.8%, now sitting on 140.13M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 27.3% and a drop 60% for the next.
Yearly Top and Bottom Value
FuelCell Energy’s stock is valued at $1.27 at 17:32 EST, way under its 52-week high of $4.36 and way higher than its 52-week low of $1.13.
More news about FuelCell Energy.
6. Ebix (EBIX) – -8.76%
Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.
NASDAQ ended the session with Ebix sliding 8.76% to $6.04 on Wednesday while NASDAQ fell 1.62% to $13,314.30.
Earnings Per Share
As for profitability, Ebix has a trailing twelve months EPS of $1.09.
PE Ratio
Ebix has a trailing twelve months price to earnings ratio of 5.54. Meaning, the purchaser of the share is investing $5.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.64%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ebix’s stock is considered to be oversold (<=20).
Moving Average
Ebix’s worth is way under its 50-day moving average of $13.62 and way under its 200-day moving average of $17.99.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Ebix’s EBITDA is 42.8.
More news about Ebix.
7. Aspen Group (ASPU) – -8.57%
Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.
NASDAQ ended the session with Aspen Group sliding 8.57% to $0.16 on Wednesday while NASDAQ slid 1.62% to $13,314.30.
Earnings Per Share
As for profitability, Aspen Group has a trailing twelve months EPS of $-0.37.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.
Yearly Top and Bottom Value
Aspen Group’s stock is valued at $0.16 at 17:32 EST, way under its 52-week high of $0.55 and way higher than its 52-week low of $0.03.
More news about Aspen Group.
8. Plug Power (PLUG) – -8.17%
Plug Power Inc. delivers end-to-end clean hydrogen and zero-emissions fuel cell solutions for supply chain and logistics applications, on-road electric vehicles, stationary power market, and others in North America and internationally. It engages in building an end-to-end green hydrogen ecosystem, including liquid green hydrogen production, storage and handling, transportation, and dispensing infrastructure. The company offers GenDrive, a hydrogen-fueled proton exchange membrane (PEM) fuel cell system that provides power to material handling electric vehicles; GenFuel, a liquid hydrogen fueling delivery, generation, storage, and dispensing system; GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive fuel cell systems, GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products, and ProGen fuel cell engines; and GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors. It also provides GenKey, an integrated turn-key solution for transitioning to fuel cell power; ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; Liquefaction systems; and Electrolyzers that are hydrogen generators optimized for clean hydrogen production. The company sells its products through a direct product sales force, original equipment manufacturers, and dealer networks. Plug Power Inc. was founded in 1997 and is headquartered in Latham, New York.
NASDAQ ended the session with Plug Power falling 8.17% to $7.09 on Wednesday while NASDAQ slid 1.62% to $13,314.30.
Earnings Per Share
As for profitability, Plug Power has a trailing twelve months EPS of $-1.43.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.73%.
More news about Plug Power.
9. Cliffs Natural Resources (CLF) – -8.11%
Cleveland-Cliffs Inc. operates as a flat-rolled steel producer in North America. The company offers hot-rolled, cold-rolled, electrogalvanized, hot-dip galvanized, galvannealed, aluminized, galvalume, enameling, and advanced high-strength steel products; stainless steel products; plates; and grain oriented and non-oriented electrical steel products. It also provides tubular components, including carbon steel, stainless steel, and electric resistance welded tubing. In addition, the company offers tinplate products, such as electrolytic tin coated and chrome coated sheet, and tin mill products; tooling and sampling; raw materials; ingots, rolled blooms, and cast blooms; and hot-briquetted iron products. Further, it owns five iron ore mines in Minnesota and Michigan. The company serves automotive, infrastructure and manufacturing, distributors and converters, and steel producers. Cleveland-Cliffs Inc. was formerly known as Cliffs Natural Resources Inc. and changed its name to Cleveland-Cliffs Inc. in August 2017. The company was founded in 1847 and is headquartered in Cleveland, Ohio.
NYSE ended the session with Cliffs Natural Resources dropping 8.11% to $14.32 on Wednesday while NYSE fell 1.39% to $15,324.96.
Earnings Per Share
As for profitability, Cliffs Natural Resources has a trailing twelve months EPS of $0.47.
PE Ratio
Cliffs Natural Resources has a trailing twelve months price to earnings ratio of 30.48. Meaning, the purchaser of the share is investing $30.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.63%.
Volatility
Cliffs Natural Resources’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.82%, a positive 0.51%, and a positive 2.05%.
Cliffs Natural Resources’s highest amplitude of average volatility was 1.70% (last week), 1.71% (last month), and 2.05% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Cliffs Natural Resources’s EBITDA is 16.61.
Volume
Today’s last reported volume for Cliffs Natural Resources is 12889100 which is 26.05% above its average volume of 10224600.
Sales Growth
Cliffs Natural Resources’s sales growth is negative 1.3% for the current quarter and 3.3% for the next.
More news about Cliffs Natural Resources.
10. Gevo (GEVO) – -7.98%
Gevo, Inc. operates as a renewable fuels company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company offers renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.
NASDAQ ended the session with Gevo falling 7.98% to $1.10 on Wednesday while NASDAQ fell 1.62% to $13,314.30.
Earnings Per Share
As for profitability, Gevo has a trailing twelve months EPS of $-0.47.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.23%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4661.8%, now sitting on 9.15M for the twelve trailing months.
More news about Gevo.
Stay up to date with our winners and losers daily report
